Short-term regulation of tyrosine hydroxylase activity and expression by endothelin-1 and endothelin-3 in the rat posterior hypothalamus

Regulatory Peptides

Volumn 142, Issue 3, 2007, Pages 69-77

  Perfume, Guadalupe ^a   Morgazo, Carolina ^a   Nabhen, Sabrina ^a   Batistone, Agustina ^a   Hope, Sandra I ^a   Bianciotti, Liliana G ^a   Vatta, Marcelo S ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Atypical ET receptor; CaMK II; Catecholaminergic transmission; ETA receptor; ETB receptor; ETC receptor; Nitric oxide pathway; Phosphoinositide pathway

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 7 NITROINDAZOLE; 8 BROMO CYCLIC GMP; BQ 610; CALMODULIN INHIBITOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLIC GMP DERIVATIVE; ENDOTHELIN 1; ENDOTHELIN 3; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; GUANYLATE CYCLASE INHIBITOR; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; KT 5823; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; PHOSPHATIDYLINOSITIDE; PHOSPHOLIPASE C; PHOSPHOLIPASE C INHIBITOR; PROTEIN KINASE C; SARAFOTOXIN S6B; SUCCINYLENDOTHELIN 1 [8-21][9 GLUTAMIC ACID 11,15 ALANINE]; TYROSINE 3 MONOOXYGENASE; UNINDEXED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CATECHOLAMINERGIC SYSTEM; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME MECHANISM; ENZYME PHOSPHORYLATION; ENZYME REGULATION; MALE; MOLECULAR MIMICRY; NEUROTRANSMISSION; NONHUMAN; POSTERIOR HYPOTHALAMUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENDOTHELIN-1; ENDOTHELIN-3; HYPOTHALAMUS, POSTERIOR; MALE; NITRIC OXIDE; OLIGOPEPTIDES; PHOSPHATIDYLINOSITOLS; PHOSPHORYLATION; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; SIGNAL TRANSDUCTION; TYROSINE 3-MONOOXYGENASE;

RATTUS;

EID: 34250192922     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2007.01.011     Document Type: Article

References (40)

1. Yanagisawa M., and Hasaki T. Molecular biology and biochemistry of endothelins. Trends Pharmacol Sci 10 (1989) 374-378
2. Kuwaki T., Kuhihara H., Cao W.H., Kurihara Y., Unekawa M., Yazaki Y., and Kumada M. Physiological role of brain endothelin in the central autonomic control: from neuron to knock out mouse. Prog Neurobiol 51 (1997) 545-579
3. Barnes K., and Turner A.J. The endothelin system and endothelin-converting enzyme in the brain: molecular and cellular studies. Neurochem Res 22 (1997) 1033-1040
4. B receptor in cardiovascular physiology and pathophysiology. Pharmacol Ther 95 (2002) 221-238
5. Motte S., Mc Entee K., and Naeije R. Endothelin receptor antagonists. Pharmacol Ther 110 (2006) 386-414
6. Stajilkovic S.S., and Catt K.J. Expression and signal transduction pathways of endothelin receptor in neuroendocrine cells. Front Neuroendocrinol 17 (1996) 327-369
7. B-selective ligands. Mol Pharmacol 52 (1997) 582-589
8. Sokolovsky M. Endothelin receptor subtypes and their role in transmembrane signalling mechanisms. Pharmacol Ther 68 (1995) 435-471
9. di Nunzio A.S., Legaz G., Rodano V., Bianciotti L.G., and Vatta M.S. Modulatory effect of endothelin-1 and -3 on neuronal norepinephrine release in the posterior hypothalamus. Regul Pept 118 (2004) 51-59
10. Karne S., Jayawickreme C.K., and Lerner M.R. Cloning and characterization of an endothelin-3 specific receptor (ETc receptor) from Xenopus laevis dermal melanophores. J Biol Chem 268 (1993) 19126-19133
11. Masaki T. Historical review: endothelin. Trends Pharmacol Sci 25 (2004) 219-224
12. Oparil S., Chen Y.F., Berecek H., Calhoun D.A., and Wyss J.M. The role of the central nervous system in hypertension. In: Laragh J.H., and Brenner B.H. (Eds). Hypertension: pathophysiology, diagnosis, and management (1995), Raven Press, New York 713-740
13. Wyss J.M., and Carlson S.H. The role of the nervous system in hypertension. Curr Hypertens Rep 3 (2001) 255-262
14. Dunkley P.R., Bobrovskaya L., Graham M.E., von Nagy-Felsobuki E.I., and Dickson P.W. Tyrosine hydroxylase phosphorylation: regulation and consequences. J Neurochem 91 (2004) 1025-1043
15. Flatmark T. Catecholamine biosynthesis and physiological regulation in neuroendocrine cells. Acta Physiol Scand 168 (2000) 1-17
16. Kumer S.C., and Vrana K.E. Intricate regulation of tyrosine hydroxylase activity and gene expression. J Neurochem 67 (1996) 443-462
17. Haycock J.W. Short- and long-term regulation of tyrosine hydroxylase in chromaffin cells by VIP and PACAP. Ann NY Acad Sci 805 (1996) 219-231
18. Kedzierski R.M., and Yanagisawa M. Endothelin system: the double-edged sword in health and disease. Annu Rev Pharmacol Toxicol 41 (2001) 851-876
19. Koizumi Y., Kataoka M., Niwa K., and Kumakura K. Endothelin-3 stimulates the release of catecholamine from cortical and striatal slices of the rat. Neurosci Lett 134 (1992) 219-222
20. Van den Buuse M., and Webber K.M. Endothelin and dopamine release. Prog Neurobiol 60 (2000) 385-405
21. di Nunzio A.S., Jaureguiberry M.S., Rodano V., Bianciotti L.G., and Vatta M.S. Endothelin-1 and -3 diminish neuronal NE release through a NO mechanism in rat anterior hypothalamus. Am J Physiol Regul Integr Comp Physiol 283 (2002) R615-R622
22. Morgazo C., Perfume G., Legaz G., di Nunzio A., Hope S.I., Bianciotti L.G., and Vatta M.S. Involvement of nitric oxide pathways in short term modulation of tyrosine hydroxylase activity by endothelins 1 and 3 in the rat anterior hypothalamus. Biochem Biophys Res Commun 334 (2005) 796-802
23. 3H].tyrosine by charcoal. Life Sci 55 (1986) 257-270
24. Holler C., Freissmuth M., and Nanoff C. G protein as drug targets. Cell Mol Life Sci 55 (1999) 257-270
25. Sluck J.M., Lin R.C.S., Katolik L.I., Jeng A.Y., and Lehmann J.C. Endothelin converting enzyme-1-, endothelin-1-, and endothelin-3-like immunoreactivity in the rat brain. Neuroscience 91 (1999) 1483-1497
26. Jedynak J.P., Ali S.F., Haycock J.W., and Hope B.T. Acute administration of cocaine regulate the phosphorylation of serine-19, -31 and -40 in tyrosine hydroxylase. J Neurochem 82 (2002) 382-388
27. Pan Y., Berman Y., Haberny S., Meller E., and Carr K.D. Synthesis, protein levels, activity, and phosphorylation state of tyrosine hydroxylase in mesoaccumbens and nidrostriatal dopamine pathways of chronically food-restricted rats. Brain Res 1122 (2006) 135-142
28. Abrahamson E.E., and Moore R.Y. The posterior hypothalamus area: chemoarchitecture and afferent connections. Brain Res 889 (2001) 1-22
29. Krukoff T.L. Central actions of nitric oxide in regulation of autonomic functions. Brain Res Rev 30 (1999) 52-65
30. Rodrigo J., Springall D.R., Uttenthal O., Ventura M.L., Abadía-Molina F., Riveros-Moreno V., Martinez-Murillo R., Pollak J.M., and Moncada S. Localization of nitric oxide synthase in the adult rat brain. Philos Trans R Soc Lond B Biol Sci 345 (1994) 175-221
31. Opgenorth T.J. Endothelin receptor antagonism. Adv Pharmacol 33 (1995) 1-65
32. B receptors involving multiple signaling pathways in the rat anterior hypothalamus. Peptides 25 (2004) 1133-1138
33. Ara J., Przedborski S., Naini A.B., Jackson-Lewis V., Trifiletti P.R., Horwitz J., and Ischiropoulos H. Inactivation on tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Proc Natl Acad Sci U S A 95 (1998) 7659-7663
34. Blanchard-Fillon B., Souza J.M., Friel T., Jiang G.C.T., Vrana K., Sharov V., Barron C., Schoneich C., Quijano C., Alvarez B., Radi R., Przedborski S., Fernando G.S., Horwitz J., and Ischiropoulos H. Nitration and inactivation of TH by peroxynitrite. J Biol Chem 276 (2001) 46017-46023
35. Abreu P., Llorente E., Sánchez J.J., and González M.C. Nitric oxide inhibits tyrosine hydroxylase of rat in median eminence. Life Sci 67 (2000) 1941-1946
36. Nakazawa T., Endo S., Shimura M., Kondo M., Ueno S., and Tamai M. Retinal G-substrate, potential downstream component of NO/cGMP/PKG pathway, is located in subtype of retinal ganglion cells and amacrine cells with protein phosphatases. Mol Brain Res 135 (2005) 58-68
37. Peng X.M., Tebranian R., Dietrich P., Stefanis L., and Perez R.G. α-Synuclein activation of protein phosphatase 2A reduce tyrosine hydroxylase phosphorylation in dopaminergic cells. J Cell Sci 118 (2005) 3523-3530
38. White R.E., Lee A.B., Shcherbatko A.D., Lincoln T.M., Schonbrunn A., and Armstrong D.L. Potassium channel stimulation by natriuretic peptide through cGMP-dependent dephosphorylation. Nature 361 (1993) 263-266
39. Vatta M.S., Rodriguéz-Fermepín M., Durante G., Bianciotti L.G., and Fernández B.E. Atrial natriuretic factor inhibits norepinephrine biosynthesis and turn over in the rat hypothalamus. Regul Pept 85 (1999) 101-107
40. Roskoski Jr. R., and Roskoski L.M. Activation of tyrosine hydroxylase in PC12 cells by the cyclic GMP and cyclic AMP second messenger system. J Neurochem 48 (1987) 236-242